Savient Pharmaceuticals (WKN 813149)

Zur Beobachtung sehr interessant, Newsflow ist auch vorhanden!

Hier ist einiges noch möglihc, oder?

Abwarten und Freuen, lg ice  

Schade trotzdem!

lg

Der heutige Tag ist nicht meiner.....  

... seit Threadbeginn!

mfg, ice  

Leg mich mal rein...

Mfg, ice  

Was werden denn hier für Kurse getaxt?! HAlloooooo  

http://de.advfn.com/...&t=17&dm=0&vol=1&cb=1136389482  

Savient jumps 14% after earnings report

BOSTON (MarketWatch) -- Shares of Savient Pharmaceuticals SVNT +15.95% jumped 14% to 66 cents a share on Wednesday after the biotech group posted a narrowed second-quarter loss. The stock has risen 8% over the last 30 days but has plunged 70% since the beginning of the year. Earlier this week, Savient adopted a shareholders rights plan to deter a possible hostile takeover by stakeholder Tang Capital Partners. Earlier this year, Tang had asserted that Savient was insolvent. On Wednesday, Savient stated it ended the second quarter with $142.2 million in cash and short-term securities. Savient's revenues largely come from its recently approved gout drug Krystexxa, which had sales of $4 million for the second quarter.

http://www.marketwatch.com/story/...s-report-2012-08-08?siteid=yhoof2  

CEO Discusses Q2 2012 Results - Earnings Call Transcript

http://seekingalpha.com/article/...nings-call-transcript?source=yahoo  

So und heute nun über die 1$.....  

 

Aus der heutige Sicht, sieht es doch sehr attraktiv aus. IMO
Bin gespannt.
GLTA ;)

Bristol-Myers Squibb Co. and Novartis AG both looked at acquiring Savient and passed because of concern about price, according to two people with knowledge of the matter, who declined to be identified because the talks are private. The board of directors will continue to “evaluate strategic alternatives,” Savient said in a statement today.

http://www.bloomberg.com/news/2010-10-25/...g-company.html?cmpid=yhoo


http://messages.finance.yahoo.com/Stocks_(A_to_Z)/...tof=15&frt=2  

BlackRock Inc. hat aufgestockt!!


Amount beneficially owned:
3113521

Percent of class
4.27%


SC 13G/A amended statement of beneficial ownership 09-10-12
http://investor.savient.com/sec.cfm  

Sehr netter Seeking Alpha Artikel über die aktuelle Situation.

http://seekingalpha.com/article/...-rising-from-the-dead?source=yahoo  

Whauuuuuu, zu Beginn sofort ein 400k Kauf!!!
Munter geht das Treiben weiter! ;)Zieehhhhh  

Weiter gehts!!! :))))  

http://www.biopharmcatalyst.com/ema-calendar/  

Erst 15 Min. und das Volumen schon über 1 Mio.!!
300K Kauf. O.o  

Für einen Freitag ein verdammt guter Lauf.

After Hours: 2,54$
Volumen 13.600  
http://www.nasdaq.com/symbol/svnt/after-hours  

Kommt sie heute, ich bin gespannt.
http://www.biopharmcatalyst.com/ema-calendar/  

Savient Receives Positive CHMP Opinion for KRYSTEXXA® Approval in the EU

http://finance.yahoo.com/news/...positive-chmp-opinion-145000794.html  

Fighting Chronic Problems: Savient’s CEO Explains
http://www.pharmalot.com/2012/10/...c-problems-savients-ceo-explains/


Ein Auszug (-das passt ja zur News vom Freitag!-):

...Pharmalot: Any other milestones coming up?
Ferrari: We’re expecting to hear back from the CHMP in Europe over the next couple of weeks on an opinion. That will be a milestone...


Wird wohl der nächste Schritt:

...Pharmalot: And how is the partnership hunt going?
Ferrari: We’re looking for a partner in Europe and the rest of the world. There are a number of companies that have expressed interest and we’re in active discussions. We don’t want to go it alone in Europe. It would have cost us $30 million or more to go forward in Europe at a time when we were battling on a lot of fronts. But right now, we have two years’ worth of cash. And we’re not under any pressure to raise any more. But we think any partnership ex-US will bring us some good revenues, including what we believe will bring upfront payments and royalties. Right now I think we’re in a pretty good spot...  

Sofort zu Beginn so ein Volumen und das ohne News?!  

Savient Pharmaceuticals Announces the Election of Genzyme CEO Dr. David Meeker to Its Board of Directors

http://finance.yahoo.com/news/...nces-election-genzyme-133000592.html


Savient's KRYSTEXXA® (pegloticase) Receives European Commission Marketing Authorization for the Treatment of Certain Patients with Chronic Tophaceous Gout

http://finance.yahoo.com/news/...ase-receives-european-164200776.html


GLTA
Bleibe dabei  

 bin heute mal eingestiegen vielleicht schafen wir ja bis 1 dollar marke  was denkt ihr???

 

Wie sieht's mit dem Eigenkapital aus?

Die produkt-Umsätze sind ja nicht gerade berauschend und decken nichtmal die kosten.

Wie lange wird das Cash noch reichen?